Back to Treatments

Treatment

Betibeglogene Autotemcel (Beti-cel / Zynteglo)

1
Conditions
5
Trials
300
Participants
35%
Average Safety

Condition Evidence

Thalassemias

5 trials · 300 participants

90% effectiveness · 35% safety
Betibeglogene Autotemcel (Beti-cel / Zynteglo) | DFDA